Financial Performance & Outlook - The company increased its FY 2019E total revenue expectation from $104 million to $109 million, and then again to $109 million to $112 million[19] - The company increased FY 2019E U S revenue expectation from $100 million to $104 million, and then again to $105 million to $107 million[19] - Strategic distribution revenue grew 42% YoY in Q3 2019, reaching $25 million compared to $17.6 million in Q3 2018[55] - Total U S product revenue increased 34% YoY in Q3 2019, from $21 million to $28.1 million[56] - The company anticipates approximately 40% revenue growth from the strategic distribution network in 2019, offset by a 22% to 28% decline in legacy and terminated distribution relationships[53] Strategic Initiatives & Innovation - The company launched 12 new products to date in 2019, aligning with its commitment to create clinical distinction[19] - New products are expected to drive over 80% of revenue by 2022, a significant increase from less than 10% in 2018 and approximately 35% in 2019E[26] - The company is focused on approach-specific procedural solutions, aiming to capture more revenue per surgical approach[42] Sales Channel & Market Adoption - The company has revitalized its sales channel by reducing distributor contracts from over 200 in 2016 to 80 in 2018, creating a strategic, exclusive network[46] - The company experienced a 17% YoY increase in revenue per case in Q3 2019, the highest rate of growth since the inception of the new ATEC[43] - Approximately 68% revenue growth from top 20 surgeons YoY reflects compelling surgeon adoption of the new ATEC[43]

UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-Q (Mark One) ☒ QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the quarterly period ended September 30, 2019 OR ☐ TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the transition period from to Commission File Number: 000-52024 ALPHATEC HOLDINGS, INC. (Exact name of registrant as specified in its charter) Delaware 20-2463898 (State or other ju ...

Alphatec Holdings, Inc. (NASDAQ:ATEC) Q3 2019 Earnings Conference Call October 30, 2019 4:30 PM ET Executives Pat Miles - Chairman and Chief Executive Officer Jeff Black - Chief Financial Officer Analysts Brooks O'Neil - Lake Street Capital Matthew O'Brien - Piper Jaffray Kyle Rose - Canaccord Sean Lee - H.C. Wainwright Operator Good afternoon, everyone, and welcome to Alphatec's Third Quarter 2019 Conference Call. We would like to remind everyone that participants on the call will make forward-looking stat ...

UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-Q (Mark One) ☒ QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the quarterly period ended June 30, 2019 OR ☐ TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the transition period from to Commission File Number: 000-52024 Delaware 20-2463898 (State or other jurisdiction of incorporation or organization)(I.R.S. Employer Identification No.) 581 ...

Alphatec Holdings, Inc. (NASDAQ:ATEC) Q2 2019 Earnings Conference Call July 24, 2019 4:30 PM ET Company Participants Patrick Miles - Executive Chairman, President and Chief Executive Officer Jeffrey Black - Executive Vice President and Chief Financial Officer Conference Call Participants Brooks O'Neil - Lake Street Capital Markets, LLC Swayampakula Ramakanth - H.C. Wainwright Operator Good afternoon, everyone and welcome to Alphatec's Second Quarter 2019 Conference Call. We would like to remind everyone tha ...

UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-Q (Mark One) ☒ QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the quarterly period ended March 31, 2019 OR ☐ TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the transition period from to Commission File Number: 000-52024 ALPHATEC HOLDINGS, INC. (Exact name of registrant as specified in its charter) Delaware 20-2463898 (State or other jurisd ...

UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, DC 20549 Form 10-K (Mark One) ☒ ANNUAL REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the fiscal year ended December 31, 2018 or ☐ TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the transition period from to Commission file number: 000-52024 ALPHATEC HOLDINGS, INC. (Exact Name of Registrant as Specified in its Charter) Delaware 20-2463898 (State or Other Jurisdiction ...